OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 75 filers reported holding OCULAR THERAPEUTIX INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $852,000 | -23.6% | 172,100 | +7.6% | 0.00% | -100.0% |
| Q4 2021 | $1,115,000 | -22.2% | 160,000 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $1,433,000 | -28.4% | 143,300 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $2,001,000 | -12.0% | 141,100 | +1.8% | 0.00% | -50.0% |
| Q1 2021 | $2,274,000 | -19.9% | 138,600 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,838,000 | +2066.4% | 137,100 | +621.6% | 0.00% | – |
| Q3 2016 | $131,000 | +39.4% | 19,000 | 0.0% | 0.00% | – |
| Q2 2016 | $94,000 | -39.7% | 19,000 | +13.1% | 0.00% | – |
| Q1 2016 | $156,000 | +27.9% | 16,800 | +29.2% | 0.00% | – |
| Q4 2015 | $122,000 | -33.3% | 13,000 | 0.0% | 0.00% | – |
| Q3 2015 | $183,000 | -19.4% | 13,000 | +20.4% | 0.00% | -100.0% |
| Q2 2015 | $227,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |